-
1
-
-
0024491638
-
Association of asthma with serum IgE levels and skin-test reactivity to allergens
-
Burrows B, Martinez FD, Halonen M, et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271-7.
-
(1989)
N Engl J Med
, vol.320
, pp. 271-277
-
-
Burrows, B.1
Martinez, F.D.2
Halonen, M.3
-
2
-
-
0030047113
-
House dust mite allergens: A major risk factor for childhood asthma in Australia
-
Peat JK, Tovey E, Toelle GB, et al. House dust mite allergens: A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996;153:141-6.
-
(1996)
Am J Respir Crit Care Med
, vol.153
, pp. 141-146
-
-
Peat, J.K.1
Tovey, E.2
Toelle, G.B.3
-
3
-
-
0026051430
-
Relationship between airway responsiveness and serum IgE in children with asthma and in apparently normal children
-
Sears MR, Burrows B, Flannery EM, et al. Relationship between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991;325:1067-71.
-
(1991)
N Engl J Med
, vol.325
, pp. 1067-1071
-
-
Sears, M.R.1
Burrows, B.2
Flannery, E.M.3
-
4
-
-
0025004551
-
Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood
-
Sporik R, Holgate ST, Platts-Mills TAE, et al. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. N Engl J Med 1990;323:502-7.
-
(1990)
N Engl J Med
, vol.323
, pp. 502-507
-
-
Sporik, R.1
Holgate, S.T.2
Platts-Mills, T.A.E.3
-
5
-
-
0026540917
-
Variations in asthma hospitalizations and death in New York
-
Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and death in New York. Am J Public Health 1992;82:59-65.
-
(1992)
Am J Public Health
, vol.82
, pp. 59-65
-
-
Carr, W.1
Zeitel, L.2
Weiss, K.3
-
6
-
-
0028870592
-
Asthma and wheezing in the first six years of life
-
The Group Health Medical Associates
-
Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.
-
(1995)
N Engl J Med
, vol.332
, pp. 133-138
-
-
Martinez, F.D.1
Wright, A.L.2
Taussig, L.M.3
-
7
-
-
0019948077
-
Reduction of bronchial hyperactivity during prolonged allergen avoidance
-
Platts Mills TAE, Tovey ER, Mitchell EB, et al. Reduction of bronchial hyperactivity during prolonged allergen avoidance. Lancet 1982;2:675-8.
-
(1982)
Lancet
, vol.2
, pp. 675-678
-
-
Platts Mills, T.A.E.1
Tovey, E.R.2
Mitchell, E.B.3
-
8
-
-
0001925097
-
Antigen-induced airway disease
-
Bush RK, editor. New York: Marcel Dekker
-
Kiekhaefer CM, Kelly EA, Jarjour NN. Antigen-induced airway disease. In: Bush RK, editor. Environmental asthma. New York: Marcel Dekker; 2001. p. 13-31.
-
(2001)
Environmental Asthma
, pp. 13-31
-
-
Kiekhaefer, C.M.1
Kelly, E.A.2
Jarjour, N.N.3
-
9
-
-
0031955159
-
An overview of antigen presentation and its central role in the immune response
-
Whitton JL. An overview of antigen presentation and its central role in the immune response. Curr Top Microbiol Immunol 1998;232:1-4.
-
(1998)
Curr Top Microbiol Immunol
, vol.232
, pp. 1-4
-
-
Whitton, J.L.1
-
10
-
-
0022640843
-
Two types of murine helper T-cell clones: Definition according to profiles of lymphokine activities and secreted proteins
-
Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T-cell clones: Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
-
(1986)
J Immunol
, vol.136
, pp. 2348-2357
-
-
Mosmann, T.R.1
Cherwinski, H.2
Bond, M.W.3
-
11
-
-
0033118157
-
Helper T-cell differentiation
-
Swain SL. Helper T-cell differentiation. Curr Opin Immunol 1999;11:180-5.
-
(1999)
Curr Opin Immunol
, vol.11
, pp. 180-185
-
-
Swain, S.L.1
-
12
-
-
0032615726
-
B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation
-
Jaffar Z, Roberts K, Pandit A, et al. B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation. Am J Respir Cell Mol Biol 1999;20:153-62.
-
(1999)
Am J Respir Cell Mol Biol
, vol.20
, pp. 153-162
-
-
Jaffar, Z.1
Roberts, K.2
Pandit, A.3
-
13
-
-
0030922681
-
Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness
-
Tsuyuki S, Tsuyuki J, Einsle K, et al. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 1997;185:1671-9.
-
(1997)
J Exp Med
, vol.185
, pp. 1671-1679
-
-
Tsuyuki, S.1
Tsuyuki, J.2
Einsle, K.3
-
14
-
-
0033043179
-
Development of T-cell memory against inhalant allergens: Risks for future
-
Holt PG. Development of T-cell memory against inhalant allergens: Risks for future. Clin Exp Allergy 1999;29(suppl 2):8-13.
-
(1999)
Clin Exp Allergy
, vol.29
, Issue.SUPPL. 2
, pp. 8-13
-
-
Holt, P.G.1
-
16
-
-
0025085559
-
Circadian basis of the late phase asthmatic response
-
Mohiuddin AA, Martin RJ. Circadian basis of the late phase asthmatic response. Am Rev Respir Dis 1990;142:1153-7.
-
(1990)
Am Rev Respir Dis
, vol.142
, pp. 1153-1157
-
-
Mohiuddin, A.A.1
Martin, R.J.2
-
17
-
-
0035888742
-
The role of immunoglobulin E in allergy and asthma
-
Platts-Mills TAE. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med 2001;164:S1-5.
-
(2001)
Am J Respir Crit Care Med
, vol.164
-
-
Platts-Mills, T.A.E.1
-
18
-
-
0034872296
-
Molecular and cellular mechanisms of allergic disease
-
Broide DH. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 2001;108:S65-71.
-
(2001)
J Allergy Clin Immunol
, vol.108
-
-
Broide, D.H.1
-
19
-
-
17644441947
-
The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: Efficacy, safety, and pharmacokinetics
-
Corne J, Djukanovic R, Thomas L, et al. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: Efficacy, safety, and pharmacokinetics. J Clin Invest 1997;99:879-87.
-
(1997)
J Clin Invest
, vol.99
, pp. 879-887
-
-
Corne, J.1
Djukanovic, R.2
Thomas, L.3
-
21
-
-
0031670214
-
Treatment of allergic airways disease with anti-IgE
-
Holgate SL, Corne J, Jardieu P, et al. Treatment of allergic airways disease with anti-IgE. Allergy 1998;53:83-8.
-
(1998)
Allergy
, vol.53
, pp. 83-88
-
-
Holgate, S.L.1
Corne, J.2
Jardieu, P.3
-
22
-
-
0035888750
-
Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders
-
Schulman ES. Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders. Am J Respir Crit Care Med 2001;164:S6-S11.
-
(2001)
Am J Respir Crit Care Med
, vol.164
-
-
Schulman, E.S.1
-
23
-
-
0029045956
-
Anti-IgE monoclonal antibodies that inhibit allergen-specific histamine release
-
Shields RL, Werther WR, Zioncheck K, et al. Anti-IgE monoclonal antibodies that inhibit allergen-specific histamine release. Int Arch Allergy Immunol 1995;107:412-3.
-
(1995)
Int Arch Allergy Immunol
, vol.107
, pp. 412-413
-
-
Shields, R.L.1
Werther, W.R.2
Zioncheck, K.3
-
24
-
-
0031065108
-
Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
-
MacGlashan DWJ, Bochner BS, Adelman DC, et al. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-45.
-
(1997)
J Immunol
, vol.158
, pp. 1438-1445
-
-
MacGlashan, D.W.J.1
Bochner, B.S.2
Adelman, D.C.3
-
25
-
-
0000655807
-
Pharmacokinetics/dynamics following administration of a recombinant humanized monoclonal anti IgE antibody in the cynomolgus monkey
-
Schoenhoff M, Bates D, Rupel J, et al. Pharmacokinetics/dynamics following administration of a recombinant humanized monoclonal anti IgE antibody in the cynomolgus monkey [abstract]. J Allergy Clin Immunol 1995;356.
-
(1995)
J Allergy Clin Immunol
, pp. 356
-
-
Schoenhoff, M.1
Bates, D.2
Rupel, J.3
-
26
-
-
0001656661
-
Initial human study with a humanized recombinant anti-IgE monoclonal antibody: Safety, tolerance and pharmacokinetic (PK)/dynamic profile
-
Froehlich J, Schoenhoff M, Tremblay T, et al. Initial human study with a humanized recombinant anti-IgE monoclonal antibody: Safety, tolerance and pharmacokinetic (PK)/ dynamic profile. Clin Pharmacol Ther 1995;57:162.
-
(1995)
Clin Pharmacol Ther
, vol.57
, pp. 162
-
-
Froehlich, J.1
Schoenhoff, M.2
Tremblay, T.3
-
27
-
-
0000655808
-
Multiple doses of a recombinant humanized monoclonal anti IgE antibody are safely tolerated and decrease free serum IgE to undetectable levels
-
Froehlich J, Schoenhoff M, Jardieu P, et al. Multiple doses of a recombinant humanized monoclonal anti IgE antibody are safely tolerated and decrease free serum IgE to undetectable levels [abstract]. J Allergy Clin Immunol 1995;356.
-
(1995)
J Allergy Clin Immunol
, pp. 356
-
-
Froehlich, J.1
Schoenhoff, M.2
Jardieu, P.3
-
28
-
-
0001526474
-
Anti-IgE treatment reduces skin test (ST) reactivity
-
Togias A, Corren J, Shapiro G, et al. Anti-IgE treatment reduces skin test (ST) reactivity [abstract]. J Allergy Clin Immunol 1998;101:S171.
-
(1998)
J Allergy Clin Immunol
, vol.101
-
-
Togias, A.1
Corren, J.2
Shapiro, G.3
-
29
-
-
8244226656
-
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response
-
Boulet LP, Chapman KR, Cote J, et al. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997;155:1835-40.
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 1835-1840
-
-
Boulet, L.P.1
Chapman, K.R.2
Cote, J.3
-
30
-
-
0030956903
-
The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
-
Fahy JV, Fleming HE, Wong HH, et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1828-34.
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 1828-1834
-
-
Fahy, J.V.1
Fleming, H.E.2
Wong, H.H.3
-
31
-
-
0032849367
-
Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects
-
Fahy JV, Cockcroft DW, Boulet L-P, et al. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1999; 160:1023-7.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, pp. 1023-1027
-
-
Fahy, J.V.1
Cockcroft, D.W.2
Boulet, L.-P.3
-
32
-
-
0034864618
-
Experiences with monoclonal antibody therapy for allergic asthma
-
Boushey Jr HA. Experiences with monoclonal antibody therapy for allergic asthma. J Allergy Clin Immunol 2001;108:S77-83.
-
(2001)
J Allergy Clin Immunol
, vol.108
-
-
Boushey H.A., Jr.1
-
33
-
-
0035888741
-
Anti-immunoglobulin E (omalizumab) therapy in allergic asthma
-
Busse WW. Anti-immunoglobulin E (omalizumab) therapy in allergic asthma. Am J Respir Crit Care Med 2001;164:S12-7.
-
(2001)
Am J Respir Crit Care Med
, vol.164
-
-
Busse, W.W.1
-
34
-
-
0033599043
-
Treatment of allergic asthma with monoclonal antiIgE antibody
-
Milgrom H, Fick Jr RB, Su JQ, et al. Treatment of allergic asthma with monoclonal antiIgE antibody. N Engl J Med 1999;341:1966-73.
-
(1999)
N Engl J Med
, vol.341
, pp. 1966-1973
-
-
Milgrom, H.1
Fick R.B., Jr.2
Su, J.Q.3
-
35
-
-
0034907372
-
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
-
Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108:184-90.
-
(2001)
J Allergy Clin Immunol
, vol.108
, pp. 184-190
-
-
Busse, W.1
Corren, J.2
Lanier, B.Q.3
-
36
-
-
0035434688
-
Treatment of childhood asthma with antiimmunoglobulin E antibody (omalizumab)
-
Milgrom H, Berger W, Nayak A, et al. Treatment of childhood asthma with antiimmunoglobulin E antibody (omalizumab). Pediatrics Electronic 2001;108:1-10.
-
(2001)
Pediatrics Electronic
, vol.108
, pp. 1-10
-
-
Milgrom, H.1
Berger, W.2
Nayak, A.3
-
37
-
-
0034881877
-
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
-
Solèr M, Matz J, Townley R, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001;18:254-61.
-
(2001)
Eur Respir J
, vol.18
, pp. 254-261
-
-
Solèr, M.1
Matz, J.2
Townley, R.3
-
38
-
-
0033836319
-
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis
-
Adelroth E, Rak S, Haahtela T, et al. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000; 106:253-9.
-
(2000)
J Allergy Clin Immunol
, vol.106
, pp. 253-259
-
-
Adelroth, E.1
Rak, S.2
Haahtela, T.3
-
39
-
-
0034878976
-
Experience with monoclonal antibodies in allergic mediated disease: Seasonal allergic rhinitis
-
Casale TB. Experience with monoclonal antibodies in allergic mediated disease: Seasonal allergic rhinitis. J Allergy Clin Immunol 2001;108:S84-8.
-
(2001)
J Allergy Clin Immunol
, vol.108
-
-
Casale, T.B.1
-
40
-
-
0030853854
-
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis
-
Casale TB, Bernstein IL, Busse WW, et al. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110-21.
-
(1997)
J Allergy Clin Immunol
, vol.100
, pp. 110-121
-
-
Casale, T.B.1
Bernstein, I.L.2
Busse, W.W.3
-
41
-
-
0036174045
-
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis
-
Kuehr J, Brauburger J, Zielen S, et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 2002;109:274-80.
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 274-280
-
-
Kuehr, J.1
Brauburger, J.2
Zielen, S.3
|